패혈증 진단 시장(2026-2030년)

The global sepsis diagnostics market is forecasted to grow by USD 581.3 mn during 2025-2030, accelerating at a CAGR of 8.7% during the forecast period. The report on the global sepsis diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing burden of sepsis and healthcare-associated infections, technological advancements in rapid molecular diagnostics and biomarkers, expansion of point-of-care testing and ai integration.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global sepsis diagnostics market is segmented as below:

By Technology

• Blood culture tests
• Molecular diagnostics
• Immunoassays
• Others

By Method

• Conventional diagnostics
• Laboratory-based testing
• POCT

By Product Type

• Consumables
• Instruments

By Type

• Bacterial sepsis
• Fungal sepsis
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the integration of ai and ml in diagnostic platforms as one of the prime reasons driving the global sepsis diagnostics market growth during the next few years. Also, expansion of decentralized point-of-care testing and microfluidic assays and strategic collaborations and multiplex syndromic testing adoption will lead to sizable demand in the market.

The report on the global sepsis diagnostics market covers the following areas:

• Global sepsis diagnostics market sizing
• Global sepsis diagnostics market forecast
• Global sepsis diagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global sepsis diagnostics market vendors that include Abbott Laboratories, Abionic SA, Beckman Coulter Inc., BioMerieux SA, Bruker Corp., Cepheid Inc., Cytovale Inc., Deepull Inc., DelphineDx, DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., Immunexpress Pty. Ltd., MicroSensDx Ltd., QIAGEN N.V., Shenzhen Mindray Co. Ltd., Siemens Healthineers AG, Snibe Co.Ltd., Sysmex Corp., Thermo Fisher Scientific Inc., Waters Corp.. Also, the global sepsis diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Market Segmentation by Method
  • Executive Summary - Chart on Market Segmentation by Product Type
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Sepsis Diagnostics Market 2020 - 2024
  • Historic Market Size - Data Table on Global Sepsis Diagnostics Market 2020 - 2024 ($ million)
• 5.2 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ million)
• 5.3 Method segment analysis 2020 - 2024
  • Historic Market Size - Method Segment 2020 - 2024 ($ million)
• 5.4 Product Type segment analysis 2020 - 2024
  • Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
• 5.5 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
• 5.6 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.7 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global sepsis diagnostics market
• 6.2 Impact of geopolitical conflicts on global sepsis diagnostics market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Technology

• 8.1 Market segments
• 8.2 Comparison by Technology
• 8.3 Blood culture tests - Market size and forecast 2025-2030
• 8.4 Molecular diagnostics - Market size and forecast 2025-2030
• 8.5 Immunoassays - Market size and forecast 2025-2030
• 8.6 Others - Market size and forecast 2025-2030
• 8.7 Market opportunity by Technology
  • Market opportunity by Technology ($ million)

9 Market Segmentation by Method

• 9.1 Market segments
• 9.2 Comparison by Method
• 9.3 Conventional diagnostics - Market size and forecast 2025-2030
• 9.4 Laboratory-based testing - Market size and forecast 2025-2030
• 9.5 POCT - Market size and forecast 2025-2030
• 9.6 Market opportunity by Method
  • Market opportunity by Method ($ million)

10 Market Segmentation by Product Type

• 10.1 Market segments
• 10.2 Comparison by Product Type
• 10.3 Consumables - Market size and forecast 2025-2030
• 10.4 Instruments - Market size and forecast 2025-2030
• 10.5 Market opportunity by Product Type
  • Market opportunity by Product Type ($ million)

11 Market Segmentation by Type

• 11.1 Market segments
• 11.2 Comparison by Type
• 11.3 Bacterial sepsis - Market size and forecast 2025-2030
• 11.4 Fungal sepsis - Market size and forecast 2025-2030
• 11.5 Others - Market size and forecast 2025-2030
• 11.6 Market opportunity by Type
  • Market opportunity by Type ($ million)

12 Customer Landscape

• 12.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

13 Geographic Landscape

• 13.1 Geographic segmentation
• 13.2 Geographic comparison
• 13.3 North America - Market size and forecast 2025-2030
  • 13.3.1 US - Market size and forecast 2025-2030
  • 13.3.2 Canada - Market size and forecast 2025-2030
  • 13.3.3 Mexico - Market size and forecast 2025-2030
• 13.4 Europe - Market size and forecast 2025-2030
  • 13.4.1 Germany - Market size and forecast 2025-2030
  • 13.4.2 UK - Market size and forecast 2025-2030
  • 13.4.3 France - Market size and forecast 2025-2030
  • 13.4.4 Italy - Market size and forecast 2025-2030
  • 13.4.5 Spain - Market size and forecast 2025-2030
  • 13.4.6 The Netherlands - Market size and forecast 2025-2030
• 13.5 Asia - Market size and forecast 2025-2030
  • 13.5.1 China - Market size and forecast 2025-2030
  • 13.5.2 India - Market size and forecast 2025-2030
  • 13.5.3 Japan - Market size and forecast 2025-2030
  • 13.5.4 South Korea - Market size and forecast 2025-2030
  • 13.5.5 Indonesia - Market size and forecast 2025-2030
  • 13.5.6 Thailand - Market size and forecast 2025-2030
• 13.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 13.6.1 Brazil - Market size and forecast 2025-2030
  • 13.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 13.6.3 UAE - Market size and forecast 2025-2030
  • 13.6.4 Turkey - Market size and forecast 2025-2030
  • 13.6.5 Argentina - Market size and forecast 2025-2030
  • 13.6.6 Colombia - Market size and forecast 2025-2030
  • 13.6.7 South Africa - Market size and forecast 2025-2030
  • 13.6.8 Israel - Market size and forecast 2025-2030
• 13.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

14 Drivers, Challenges, and Opportunity

• 14.1 Market drivers
  • Increasing burden of sepsis and healthcare-associated infections
  • Technological advancements in rapid molecular diagnostics and biomarkers
  • Expansion of point-of-care testing and AI integration
• 14.2 Market challenges
  • High cost of advanced diagnostic equipment and consumables
  • Unfavorable reimbursement policies and complex regulatory frameworks
  • Scarcity of skilled laboratory personnel and lack of awareness
• 14.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 14.4 Market opportunities
  • Integration of AI and ML in diagnostic platforms
  • Expansion of decentralized point-of-care testing and microfluidic assays
  • Strategic collaborations and multiplex syndromic testing adoption

15 Competitive Landscape

• 15.1 Overview
• 15.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 15.3 Landscape disruption
  • Overview on factors of disruption
• 15.4 Industry risks
  • Impact of key risks on business

16 Competitive Analysis

• 16.1 Companies profiled
  • Companies covered
• 16.2 Company ranking index
  • Company ranking index
• 16.3 Market positioning of companies
  • Matrix on companies position and classification
• 16.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 16.5 Abionic SA
  • Abionic SA - Overview
  • Abionic SA - Product / Service
  • Abionic SA - Key offerings
  • SWOT
• 16.6 BioMerieux SA
  • BioMerieux SA - Overview
  • BioMerieux SA - Business segments
  • BioMerieux SA - Key offerings
  • BioMerieux SA - Segment focus
  • SWOT
• 16.7 Bruker Corp.
  • Bruker Corp. - Overview
  • Bruker Corp. - Business segments
  • Bruker Corp. - Key offerings
  • Bruker Corp. - Segment focus
  • SWOT
• 16.8 DelphineDx
  • DelphineDx - Overview
  • DelphineDx - Product / Service
  • DelphineDx - Key offerings
  • SWOT
• 16.9 DiaSorin SpA
  • DiaSorin SpA - Overview
  • DiaSorin SpA - Business segments
  • DiaSorin SpA - Key news
  • DiaSorin SpA - Key offerings
  • DiaSorin SpA - Segment focus
  • SWOT
• 16.10 EKF Diagnostics Holdings Plc
  • EKF Diagnostics Holdings Plc - Overview
  • EKF Diagnostics Holdings Plc - Business segments
  • EKF Diagnostics Holdings Plc - Key offerings
  • EKF Diagnostics Holdings Plc - Segment focus
  • SWOT
• 16.11 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 16.12 QIAGEN N.V.
  • QIAGEN N.V. - Overview
  • QIAGEN N.V. - Product / Service
  • QIAGEN N.V. - Key offerings
  • SWOT
• 16.13 Shenzhen Mindray Co. Ltd.
  • Shenzhen Mindray Co. Ltd. - Overview
  • Shenzhen Mindray Co. Ltd. - Business segments
  • Shenzhen Mindray Co. Ltd. - Key offerings
  • Shenzhen Mindray Co. Ltd. - Segment focus
  • SWOT
• 16.14 Siemens Healthineers AG
  • Siemens Healthineers AG - Overview
  • Siemens Healthineers AG - Business segments
  • Siemens Healthineers AG - Key offerings
  • Siemens Healthineers AG - Segment focus
  • SWOT
• 16.15 Snibe Co.Ltd.
  • Snibe Co.Ltd. - Overview
  • Snibe Co.Ltd. - Product / Service
  • Snibe Co.Ltd. - Key offerings
  • SWOT
• 16.16 Sysmex Corp.
  • Sysmex Corp. - Overview
  • Sysmex Corp. - Business segments
  • Sysmex Corp. - Key offerings
  • Sysmex Corp. - Segment focus
  • SWOT
• 16.17 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT
• 16.18 Waters Corp.
  • Waters Corp. - Overview
  • Waters Corp. - Business segments
  • Waters Corp. - Key offerings
  • Waters Corp. - Segment focus
  • SWOT

17 Appendix

• 17.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 17.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 17.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 17.4 Research methodology
  • Research methodology
• 17.5 Data procurement
  • Information sources
• 17.6 Data validation
  • Data validation
• 17.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 17.8 Data synthesis
  • Data synthesis
• 17.9 360 degree market analysis
  • 360 degree market analysis
• 17.10 List of abbreviations
  • List of abbreviations